NCT07293468 2026-04-09
BIIRTH
Tuen Mun Hospital
Phase 2/3 Recruiting
Clinical Trials
7 trialsNCT07502118 2026-03-30
NexCAR19
Health Institutes of Turkey
Phase 2/3 Recruiting
NCT07472140 2026-03-16
PARP (Poly (ADP-ribose) Polymerase) Inhibitor With or Without Angiogenesis Inhibitor in Homologous Recombination Deficient Primary Ovarian Cancer, Fallopian-Tube Cancer, or Primary Peritoneal Cancer
N.N. Alexandrov National Cancer Centre
Phase 2/3 Recruiting
NCT07472153 2026-03-16
PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer
N.N. Alexandrov National Cancer Centre
Phase 2/3 Recruiting
NCT07272772 2025-12-09
Colon Cancer Diagnosis With FAPI-PET Imaging
Turku University Hospital
Phase 2/3 Recruiting
NCT07098598 2025-08-01
Pancreatic Cancer Diagnosis With FAPI-PET Imaging
Turku University Hospital
Phase 2/3 Recruiting
NCT02035098 2025-06-11
Improving Pain Management in Hospitalized Cancer Patients. A Before-after Cluster Phase II Trial
Azienda USL Reggio Emilia - IRCCS
Phase 2/3 Completed